CC5 Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume1.22M
Average Volume (3M)1.61M
Market Cap
AU$45.77M
Enterprise ValueAU$48.85M
Total Cash (Recent Filing)AU$3.10M
Total Debt (Recent Filing)AU$1.31M
Price to Earnings (P/E)30.0
Beta2.04
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,179,622,800
10 Day Avg. Volume2,124,004
30 Day Avg. Volume1,608,700
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)4.89
Price to Sales (P/S)5.06
P/FCF Ratio-23.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$4.00M
LBT Innovations Limited News
CC5 FAQ
What was LBT Innovations Limited’s price range in the past 12 months?
LBT Innovations Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is LBT Innovations Limited’s market cap?
LBT Innovations Limited’s market cap is AU$45.77M.
When is LBT Innovations Limited’s upcoming earnings report date?
LBT Innovations Limited’s upcoming earnings report date is Sep 02, 2026 which is in 60 days.
How were LBT Innovations Limited’s earnings last quarter?
LBT Innovations Limited released its earnings results on Feb 16, 2026. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is LBT Innovations Limited overvalued?
According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued.
Does LBT Innovations Limited pay dividends?
LBT Innovations Limited does not currently pay dividends.
What is LBT Innovations Limited’s EPS estimate?
LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LBT Innovations Limited have?
LBT Innovations Limited has 2,179,622,800 shares outstanding.
What happened to LBT Innovations Limited’s price movement after its last earnings report?
LBT Innovations Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LBT Innovations Limited?
Currently, no hedge funds are holding shares in AU:CC5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LBT Innovations Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CC5 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
100.00%
12-Months-Change
Fundamentals
Return on Equity
41.75%
Trailing 12-Months
Asset Growth
19.89%
Trailing 12-Months
Company Description
LBT Innovations Limited
Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Technical Analysis
Senetas Corporation Limited
―
QuickFee Ltd.
―
Peppermint Innovation Limited
―
Sovereign Cloud Holdings Ltd.
―
HSC Technology Group Ltd.
―
Options Prices
Currently, No data available
---







